Roy Eldor Selected Research

Roy Eldor Research Topics

14	Type 2 Diabetes Mellitus (MODY) 03/2024 - 04/2005
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2022 - 05/2009
6	Insulin Resistance 01/2017 - 11/2010
4	Diabetes Complications 03/2024 - 01/2019
4	Body Weight (Weight, Body) 01/2018 - 01/2018
3	Obesity 01/2023 - 12/2012
3	Inflammation (Inflammations) 01/2023 - 01/2015
3	Infections 10/2021 - 01/2018
3	Hyperglycemia 02/2014 - 05/2009
2	Cognitive Dysfunction 01/2024 - 01/2017
2	Albuminuria 01/2022 - 01/2017
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2021 - 01/2021
2	Diabetes Mellitus 10/2021 - 02/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2016 - 08/2014
1	Weight Loss (Weight Reduction) 10/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Weight Gain 01/2023
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Ulcer 01/2022
1	Heart Failure 10/2021
1	Chronic Disease (Chronic Diseases) 10/2021
1	Dementia (Dementias) 10/2021
1	COVID-19 10/2021
1	Glycosuria 01/2019
1	Ketosis 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Lactic Acidosis 01/2019
1	Disease Progression 01/2015
1	Hypertension (High Blood Pressure) 12/2012
1	Spinal Fractures 05/2012

15	Insulin (Novolin)FDA Link 03/2024 - 06/2005
9	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 04/2005
5	LipidsIBA 01/2024 - 04/2005
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2015
3	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2021 - 02/2014
2	ORMD-0801IBA 01/2023 - 01/2013
2	CreatinineIBA 10/2021 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 10/2021 - 01/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 05/2012
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2018
2	MK-1293IBA 01/2018 - 01/2018
2	ertugliflozinIBA 01/2018 - 01/2018
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2018 - 01/2018
2	Insulin Glargine (Lantus)FDA Link 01/2018 - 01/2018
2	InsulinsIBA 01/2018 - 01/2018
2	dapagliflozinIBA 11/2016 - 02/2014
2	Adenosine Triphosphate (ATP)IBA 11/2016 - 08/2014
1	semaglutideIBA 10/2023
1	C-Reactive ProteinIBA 01/2023
1	VaccinesIBA 10/2021
1	Vitamin D FDA LinkGeneric 10/2021
1	VitaminsIBA 10/2021
1	IronIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	ElectrolytesIBA 01/2019
1	empagliflozinIBA 01/2019
1	Apolipoprotein E4IBA 01/2017
1	AlbuminsIBA 01/2017
1	Glucagon (Glukagon)FDA Link 11/2016
1	KetonesIBA 11/2016
1	Nonesterified Fatty Acids (NEFA)IBA 08/2014
1	Sodium-Glucose Transport ProteinsIBA 02/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2013
1	Blood Glucose (Blood Sugar)IBA 01/2013
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2012
1	SecretagoguesIBA 12/2012
1	Protein Kinase C-alphaIBA 08/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2010
1	AntigensIBA 05/2009

3	Therapeutics 10/2023 - 12/2012
3	Glycemic Control 01/2022 - 08/2013
1	Ambulatory Care (Outpatient Care) 01/2024
1	Off-Label Use 10/2023
1	Surgical Amputation (Amputations) 01/2022
1	Caloric Restriction 01/2019
1	Resistance Training 01/2019
1	Mediterranean Diet 01/2019
1	Transplantation 01/2013